THE KOG REPORTTHE KOG REPORT:
In last week’s KOG Report we mentioned the importance of the levels we had in mind for the week ahead and to expect some movement in the markets while it attempts to break out of the range it’s been accumulating in.
We mentioned the level of 2022-20 as the initial level, where if price found support, we felt an opportunity to long the market back into the order region would be available to traders, but only on the scalp, which as you can see happened nearly to the pip. We then said we would be looking for a reaction in price around that region and felt an opportunity to short from there back down in attempt to break the support and target the 2010 level would be available.
The levels and plan worked well giving traders opportunities both ways netting phenomenal pip captures and trading this the way it should be done in a ranging market. We also completed our daily bias targets as well as Excalibur targets. We then closed in a potential move on the way to target but we suggested traders take what the market gives and we’ll start fresh again on market open.
A fantastic week again in Camelot, not only on gold but the numerous other pairs we trade.
So, what can we expect in the week ahead?
This week again, we’ll stick to a similar plan and look for lower pricing. Only this time, we’ll be expecting a bounce from the lower support regions which we feel will give sharp move, so please be careful not to short or long too early!
We have the levels of 2020-18 and below that 2010-08, if this regions are attempted from opening, we feel an opportunity to long the market back up into the 2025-7 and above that 2030-35 levels are available, it is here that we want to see price stall. If it does, as shown in path we feel we can again attempt to short the market with the plan to break below that 2000 level targeting lower support before the bounce we’re looking for.
Please note, this all depends on the price staying below the order region during the early sessions, as breaking above will lead to further gains before we then see a reaction from higher up in the pool and get another opportunity to short. It sounds like a long-winded process, but putting a complex plan into one idea like we do takes some work.
The path and levels should help you along the way as well the daily updates and KOG’s bias of the day. Please keep an eye out for these!
Please do support us by hitting the like button, leaving a comment, and giving us a follow. We’ve been doing this for a long time now providing traders with in-depth free analysis on Gold, so your likes and comments are very much appreciated.
As always, trade safe.
KOG
Tradingexperts
Pfizer and BioNTech Dose First Participants in the U.S. Hey fellow Traders from TradingView, this is an update to the actual Situation and my previous Analysis
If you agree with my Analysis or find it useful , please leave me a like for my work it would be greatly appreciated.
Im still bullish and optimistic that BNTX participation will have a huge global impact. The stock seems to be news related, so expect it to make huge moves when they finally will announce to have completed those first worldwide clinical studies.
The Moving Averages are lining up and signalizing us there will soon be a Price expansion.
Assuming the 55 MA line serves as a support we cacn expect the stock to bounce off that and rise to the resistance battleground area.
I´d place my Stop Loss below the next support pivot at either 36.85 to not risk gettiong shaken out before the upcoming outbreak. If you can handle that amount of risk.
If not a LOD SL is always a great way to reduce risk.
Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) announced today that the first participants have been dosed in the U.S. in the Phase 1/2 clinical trial for the BNT162 vaccine program to prevent COVID-19. This U.S. trial is part of a global development program, and the dosing of the first cohort in Germany was completed last week.
"The Phase 1/2 study is designed to determine the safety, immunogenicity and optimal dose level of four mRNA vaccine candidates, and is to be evaluated in a single, continuous study. The dose level escalation portion (Stage 1) of the Phase 1/2 trial in the U.S. will enroll up to 360 healthy subjects into two age cohorts (18-55 and 65-85 years of age). The first subjects immunized in Stage 1 of the study will be healthy adults 18-55 years of age. Older adults will only be immunized with a given dose level of a vaccine candidate once testing of that candidate and dose level in younger adults has provided initial evidence of safety and immunogenicity. Sites currently dosing participants include NYU Grossman School of Medicine and the University of Maryland School of Medicine. The University of Rochester Medical Center/Rochester Regional Health and Cincinnati Children’s Hospital Medical Center will begin enrollment shortly."
Source by: NASDAQ:BNTX FWB:22UA investors.biontech.de
Remember, this is only my opinion after considering all facts and informing myself about the Up/Downside of this stock.
So no financial advise is given here. Always do your own reasearch.
Thank you for taking the time and i hope to see you again in my next post!
See you there
Sincerly,
Sebastian - TradingExperts Europe
SPX 500 | Be aware of the 200 MA | Cup & Handle PatternHey guys, Please support this idea with a LIKE or COMMENT if you find it useful.
After an in-depht Analysis of the SPY and the Big players with the biggest Market Cap, i would like to share this with you:
Today we saw a little Market weakness from AMZN, GOOGL, SHOP, NFLX,FB with a little sell off after we hit the overhead resistance.
But the SPY seems strong and the levels intact. RSI also pointing forward.
This could be a potential sign for a retracment from the 100 & 200 Moving Averages. That means we currently forming a new range where the market looks for a support which is has found at around 2700 Points.
Be careful when we reach this level and we dont have market strength behind us. Then in my opinion we could see a pull back to around 2400
BUT remember PRICE ACTION tells the Story not the News.
So if we get a Volume spike when approaching those upper levels its a good sign for staying Long and Optimistic with this specific Asset.
Im staying LONG but with a tight stop loss to keep my gains!!
Remmber this is only my Opinion and in no way financial Advise - Keep doing your own Research and never forget to keep a tight and proper risk managment in place.
Thanks for taking your time to read this!
Sincerly,
Sebastian - Trading Experts EU TVC:SPX